COMP <GO>
SGRY vs AXGN // REVENUE GROWTH (YOY)
Surgery Partners Inc. (NASDAQ) VS. Axogen Inc. (NASDAQ) • 15-METRIC TALLY: SGRY 6
— AXGN 5
▲ REVENUE GROWTH (YOY) LEADER: AXGN
LAST: $23.21 (-0.13%) • MKT CAP: $3.04B
revenue-growth
6.60%
LAST: $49.63 (+0.77%) • MKT CAP: $2.96B
revenue-growth
20.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGRY VS. AXGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SGRY | AXGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | -2.60% | +12.50 | SGRY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.7x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.44% | -0.10% | +6.54 | SGRY | /fcf-yield <GO> |
| Operating Margin | 45.80% | -3.50% | +49.30 | SGRY | /operating-margins <GO> |
| Net Profit Margin | -9.20% | -7.00% | -2.20 | AXGN | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 6.60% | 20.20% | -13.60 | AXGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.67 | 18.64 | -17.97 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | SGRY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 86.2 | 74.3 | +11.90 | SGRY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.10 | -0.11 | AXGN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 18.0x | +4.00 | AXGN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.04B | $2.96B | $74.2M | SGRY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SGRY REV | AXGN REV | SGRY GROSS % | AXGN GROSS % | SGRY FCF | AXGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $225.2M | — | 74.3% | $195.6M | -$2.9M |
| FY 2024 | $0 | $187.3M | — | 75.8% | $209.7M | $1.4M |
| FY 2023 | $0 | $159.0M | — | — | $293.8M | -$12.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGRY // BETA 0.99
AXGN // BETA 1.10